ArticleTranslational lung cancer research2026
Prognostic factors of epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor (TKI): a nationwide registry study in China.
Wenhua Liang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.